Literature DB >> 30006055

Diaphanospondylodysostosis: Refining the prenatal diagnosis of a rare skeletal disorder.

Lior Greenbaum1, Yinon Gilboa2, Annick Raas-Rothschild3, Ortal Barel4, Nitzan Kol4, Haike Reznik-Wolf5, Ben Pode-Shakked6, Yael Finezilber5, Baruch Messing7, Michal Berkenstadt8.   

Abstract

Diaphanospondylodysostosis (DSD) is a rare autosomal recessive skeletal disorder, characterized mainly by ossification defects in vertebrae, thorax malformations, renal cystic dysplasia and usually death in the perinatal period. DSD is caused by mutations in the bone morphogenetic protein-binding endothelial regulator (BMPER) gene. We describe the prenatal findings of a non-consanguineous Jewish couple (shared Balkan origin), with three affected fetuses that presented with malformations in the spine and chest, reduced ossification of the skull and spine, horseshoe kidney and increased nuchal translucency. The unique combination of these ultrasound (US) features raised the possibility of DSD, which was confirmed by whole exome sequencing (WES) performed on a single fetal DNA and familial segregation. In the three fetuses, a novel homozygous mutation in BMPER (c.410T > A; p.Val137Asp) was found. This mutation, which segregated in the family, was not found in 65 controls of Jewish Balkan origin, and in several large databases. Taken together, the combination of a detailed prenatal US examination and WES may be highly effective in confirming the diagnosis of a rare genetic disease, in this case DSD.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  BMPER; Diaphanospondylodysostosis; Ischiospinal dysostosis; Skeletal dysplasia

Mesh:

Substances:

Year:  2018        PMID: 30006055     DOI: 10.1016/j.ejmg.2018.07.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  Evaluation of Diagnostic Yield in Fetal Whole-Exome Sequencing: A Report on 45 Consecutive Families.

Authors:  Lior Greenbaum; Ben Pode-Shakked; Shlomit Eisenberg-Barzilai; Michal Dicastro-Keidar; Anat Bar-Ziv; Nurit Goldstein; Haike Reznik-Wolf; Hana Poran; Amihai Rigbi; Ortal Barel; Aida M Bertoli-Avella; Peter Bauer; Miriam Regev; Annick Raas-Rothschild; Elon Pras; Michal Berkenstadt
Journal:  Front Genet       Date:  2019-06-25       Impact factor: 4.599

2.  Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells.

Authors:  Yong Xi; Xin Nie; Jing Wang; Lingling Gao; Bei Lin
Journal:  Biomed Res Int       Date:  2020-03-24       Impact factor: 3.411

3.  Successfully Managed Respiratory Insufficiency in a Patient with a Novel Pathogenic Variant of the BMPER Gene: A Case Report.

Authors:  Ho Eun Park; Jin A Yoon; Yong Beom Shin
Journal:  Diagnostics (Basel)       Date:  2022-03-03

4.  Expansion of the mutational spectrum of BMPER leading to diaphanospondylodysostosis and description of the associated disease process.

Authors:  Frederik Braun; Andrea Gangfuß; Petra Stöbe; Tobias B Haack; Bernd Schweiger; Andreas Roos; Ulrike Schara
Journal:  Mol Genet Genomic Med       Date:  2021-07-20       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.